Medical Union Pharmaceuticals

MUP, established in 1984 to develop the regional pharmaceutical market, has become a leading international pharmaceutical company generating revenue of around 2.4 billion Egyptian pounds in 2018. With a balanced business model for sustainability covering branded generics and biosimilars diversified by geography and product, MUP operates in more than 40 countries across three continents with 2,357 employees globally, developing, manufacturing and marketing a broad range of branded and non-branded generic pharmaceutical products across the Middle East, Africa, CIS and Eastern Europe, aiming to improve lives with high-quality, affordable medicines while building long-term value for shareholders and a sustainable business for employees and communities.